Recent development in 2-pyrrolidinone-containing nootropics-Reference-Cited by-同舟云学术

Recent development in 2-pyrrolidinone-containing nootropics

Published:1989 Issue:3 Volume:18 Page:177-189
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Gamzu Elkan,Hoover Toni M.,Gracon Stephen I.,Ninteman Monica V.

Publisher

Wiley

Subject

Drug Discovery

Reference90 articles.

1. American Psychiatric Association. ?Diagnostic and statistical of mental disorders.? 3rd Ed., revised. Washington, DC: American Psychiatric Association, 1987.

2. Enhancement of radial maze performances in CD1 mice after prenatal exposure to oxiracetam: Possible role of sustained investigative responses developed during ontogeny

3. 2-Pyrrolidinone and succinimide endogenously present in several mammalian species

4. Experimental Behavioral Studies with Oxiracetam on Different Types of Chronic Cerebral Impairment

5. Treatment of alcohol organic mental disorder with piracetam

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nickel(0)-Catalyzed [2 + 2 + 1] Carbonylative Cycloaddition of Imines and Alkynes or Norbornene Leading to γ-Lactams;Journal of the American Chemical Society;2014-11-04

2. Direct Synthesis of 4-Acetyl-1-alkyl-1H-pyrrol-2(5H)-ones from Difunctionalized Allyl Bromide;Synthetic Communications;2014-10-10

3. 2-Pyrrolidone;Ullmann's Encyclopedia of Industrial Chemistry;2011-10-15

4. Ocimum sanctum Linn. Leaf Extracts Inhibit Acetylcholinesterase and Improve Cognition in Rats with Experimentally Induced Dementia;Journal of Medicinal Food;2011-09

5. Effects of the cognition impairer MK-801 on learning and memory in mice and rats;Behavioural Brain Research;2011-06